Ingo Ringshausen
Clinical challenge: fatal mucormycotic osteomyelitis caused by Rhizopus microsporus despite aggressive multimodal treatment
Harrasser N, Ringshausen I, von Eisenhart-Rothe R, Peschel C, Toepfer A, Prodinger P, Lenze U, Hauschild M, Banke I, Verbeek M. Clinical challenge: fatal mucormycotic osteomyelitis caused by Rhizopus microsporus despite aggressive multimodal treatment. BMC Infect Dis 2014; 14:488.
06.09.2014Clinical challenge: fatal mucormycotic osteomyelitis caused by Rhizopus microsporus despite aggressive multimodal treatment
06.09.2014BMC Infect Dis 2014; 14:488
Harrasser Norbert, Ringshausen Ingo, von Eisenhart-Rothe Rüdiger, Peschel Christian, Toepfer Andreas, Prodinger Peter M, Lenze Ulrich, Hauschild Matthias, Banke Ingo J, Verbeek Mareike
Antifungal therapy with itraconazole impairs the anti-lymphoma effects of rituximab by inhibiting recruitment of CD20 to cell surface lipid rafts
Ringshausen I, Feuerstacke Y, Krainz P, den Hollander J, Hermann K, Buck A, Peschel C, Meyer Zum Bueschenfelde C. Antifungal therapy with itraconazole impairs the anti-lymphoma effects of rituximab by inhibiting recruitment of CD20 to cell surface lipid rafts. Cancer Res 2010; 70:4292-6.
11.05.2010Antifungal therapy with itraconazole impairs the anti-lymphoma effects of rituximab by inhibiting recruitment of CD20 to cell surface lipid rafts
11.05.2010Cancer Res 2010; 70:4292-6
Ringshausen Ingo, Feuerstacke Yvonne, Krainz Philipp, den Hollander Jürgen, Hermann Ken, Buck Andreas, Peschel Christian, Meyer Zum Bueschenfelde Christian